Get article recommendations from ACS based on references in your Mendeley library. Pair your accounts. Export articles to Mendeley Get article recommendations from ACS based on references in your ...

Abstract: The papers in this special section were taked from the analog, data converter, RF, wireless, and wireline communications sessions at the IEEE International Solid-State Circuits Conference ...

A NOTE ABOUT RELEVANT ADVERTISING: We collect information about the content (including ads) you use across this site and use it to make both advertising and content more relevant to you on our ...

University of Arkansas for Medical Sciences/Arkansas Children’s Hospital Research Institute, Little Rock, Arkansas 72202, University of Arkansas, Fayetteville, Arkansas 72701, U.S. Food and Drug ...

The next best? Rickie Fowler at -47 in 45 rounds. We live in an age when any and every topic can be hot-taked and tweeted to death, including the merits of 18 golf holes. ‘Touch grass’ goes ...

Aim To describe the clinical features, management and correlation of the American Joint Committee on Cancer tumour node metastasis (TNM) staging for eyelid carcinoma with outcomes in Japanese patients ...

Yankees third baseman Oswaldo Cabrera was taken off the field in an ambulance after he injured his left ankle in the ninth inning of New York's 11-5 victory over Seattle on Monday night. Cabrera ...

India has 29 states with at least 720 districts comprising of approximately 6 lakh villages, and over 8200 cities and towns. Indian postal department has allotted a unique postal code of pin code ...

Enhertu delivered a phase 3 trial win in early-stage breast cancer. Takeda spotlighted three late-stage readouts as a potential "inflection point" for the company. President Donald Trump is ...

TOKYO -- Japanese drugmaker Takeda Pharmaceuticals will invest $30 billion in the U.S. over the next five years, CEO Christophe Weber said Thursday, with the money going toward both manufacturing ...

Take­da re­vealed a hand­ful of pipeline cuts in its fourth-quar­ter earn­ings re­sults on Thurs­day, as the com­pa­ny fo­cus­es its at­ten­tion on six late-stage pro­grams it … ...